CS
Chris Schott JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
5.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
87%
Neutral
13%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Overweight
Upgraded
| $24 |
10%
upside
| 1 | +5.1% |
0
%
| 7 Oct ‘25 13 days ago |
|
|
Overweight
Maintained
| $26 |
34%
upside
| 3 | +7.7% |
0
%
| 3 Oct ‘25 17 days ago |
|
|
Overweight
Maintained
| $145 |
18%
upside
| 5 | +6.2% |
0
%
| 16 Sep ‘25 1 month ago |
|
|
Overweight
Maintained
| $1,050 |
30%
upside
| 2 | +12% |
0
%
| 16 Sep ‘25 1 month ago |
|
|
Overweight
Maintained
| $14 |
37%
upside
| 2 | +15% |
0
%
| 16 Sep ‘25 1 month ago |
|
|
Overweight
Maintained
| $235 |
1%
upside
| 2 | +17% |
0
%
| 16 Sep ‘25 1 month ago |
|
|
Overweight
Maintained
| $35 |
61%
upside
| 1 | -8.1% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Overweight
Maintained
| $675 |
5%
upside
| 1 | +20% |
0
%
| 4 Aug ‘25 2 months ago |
|
|
Overweight
Maintained
| $800 |
39%
upside
| 4 | -9.9% |
0
%
| 9 Jun ‘25 4 months ago |
|
|
Neutral
Maintained
| $175 |
19%
upside
| 2 | – |
–
| 5 May ‘25 5 months ago |
|